Epicrispr Biotechnologies
Latest round
- Grant
Last raised
- Oct 2026
Total raised
- $166M
Investors
- 11
About Epicrispr Biotechnologies
Founded in 2018 by Lei Stanley Qi and based in California, US, Epicrispr Biotechnologies, Inc. is a biotechnology company developing ultracompact therapies to modulate gene expression. As of January 2023, Amber Salzman serves as the CEO of the company. In August 2026, Epicrispr Biotechnologies, Inc. The company provides a platform, called the Gene Expression Modulation System (GEMS), that combines a DNA-binding protein, a customised guide RNA, and any of a wide array of modulator proteins to create a new type of genetic medicine. GEMS therapies can modulate gene expression both in vivo and ex vivo and are mutation-agnostic. The firm also holds a licence for the miniature DNA-binding protein called CasMINI, which is the dCas protein that can work in human cells. The company’s product pipeline includes EPI-321, facioscapulohumeral muscular dystrophy (FSHD), EPI-221, heterozygous familial hypercholesterolemia (HeFH), EPI-241, alpha-1 antitrypsin deficiency (A1AD), EPI-141, retinitis pigmentosa 4 (RP4), and EPI-111, retinitis pigmentosa 11 (RP11).
Who invested in Epicrispr Biotechnologies
11 investors across 3 rounds
See all investors in Epicrispr Biotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Epicrispr Biotechnologies
Who invested in Epicrispr Biotechnologies?
Epicrispr Biotechnologies has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Epicrispr Biotechnologies raised?
Epicrispr Biotechnologies has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Epicrispr Biotechnologies last raise money?
Epicrispr Biotechnologies's most recent round on record is a Grant, in Oct 2026.
What does Epicrispr Biotechnologies do?
Founded in 2018 by Lei Stanley Qi and based in California, US, Epicrispr Biotechnologies, Inc.
Where is Epicrispr Biotechnologies headquartered?
Epicrispr Biotechnologies is headquartered in South San Francisco, US.
Which VCs invest in companies like Epicrispr Biotechnologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Epicrispr Biotechnologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Grant
Raising like Epicrispr Biotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.